Among potential therapeutic targets for BC, Sorokin et al. found that the mediator of ErbB2-driven cell motility 1 (MEMO1) is involved in IGF-1-mediated EMT induction in BC cell lines, mostly in MCF10A cells [177]. This evidence concerns the gene IGF1 and breast cancer.